The relationship between the parent drug and it’s metabolite is an important part of drug testing.

New Entryway

Acutis Diagnostics (, a New York headquartered clinical toxicology laboratory, has announced that it has acquired 11,000 square feet of additional space in East Northport, New York to support the ongoing growth of its medication monitoring and drugs of abuse testing operations. The new facility is designed with state of the art clinical laboratorial amenities.

Featured in: